STOCK TITAN

[8-K] Neuraxis, Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Barrett Business Services Inc. (BBSI) – Insider Form 4 filing dated 7 July 2025

Director Alexandra Morehouse McReynolds reported the following equity transactions executed on 1 July 2025:

  • 3,064 common shares acquired (Transaction Code M) upon the vesting/settlement of an equal number of Restricted Stock Units (RSUs) at an exercise price of $0.00. This increased her direct common-stock holdings to 13,084 shares.
  • The underlying RSU position tied to the exercised award was reduced to zero.
  • On the same date, the director received a new grant of 2,344 RSUs (Transaction Code A). These RSUs vest in a single tranche on 1 July 2026 and, once vested, will convert 1-for-1 into unrestricted common shares.

No shares were sold and no derivatives were disposed of for cash consideration. All reported equity was acquired at no cost, reflecting scheduled board-compensation awards. After the transactions, Ms. McReynolds holds 13,084 common shares directly and 2,344 RSUs that remain unvested.

The filing signals continued equity alignment between the director and shareholders, but does not, by itself, represent a material corporate event for BBSI.

Barrett Business Services Inc. (BBSI) – Comunicazione interna Modulo 4 datata 7 luglio 2025

La direttrice Alexandra Morehouse McReynolds ha riportato le seguenti operazioni azionarie eseguite il 1 luglio 2025:

  • Acquisizione di 3.064 azioni ordinarie (Codice Transazione M) a seguito della maturazione/estinzione di un pari numero di Restricted Stock Units (RSU) con un prezzo di esercizio di $0,00. Ciò ha portato il suo possesso diretto di azioni ordinarie a 13.084 azioni.
  • La posizione sottostante delle RSU legate all’assegnazione esercitata è stata azzerata.
  • Nello stesso giorno, la direttrice ha ricevuto una nuova assegnazione di 2.344 RSU (Codice Transazione A). Queste RSU maturano in un’unica tranche il 1 luglio 2026 e, una volta maturate, si convertiranno 1 a 1 in azioni ordinarie senza restrizioni.

Non sono state vendute azioni né ceduti derivati per contante. Tutte le azioni riportate sono state acquisite a costo zero, in linea con le assegnazioni programmate per la remunerazione del consiglio. Dopo le transazioni, la signora McReynolds detiene 13.084 azioni ordinarie direttamente e 2.344 RSU ancora non maturate.

La comunicazione evidenzia un continuo allineamento azionario tra la direttrice e gli azionisti, ma non rappresenta di per sé un evento societario rilevante per BBSI.

Barrett Business Services Inc. (BBSI) – Presentación interna Formulario 4 fechada el 7 de julio de 2025

La directora Alexandra Morehouse McReynolds informó las siguientes transacciones de acciones realizadas el 1 de julio de 2025:

  • Adquisición de 3,064 acciones comunes (Código de Transacción M) tras el otorgamiento/liquidación de un número igual de Unidades de Acciones Restringidas (RSU) a un precio de ejercicio de $0.00. Esto incrementó su tenencia directa de acciones comunes a 13,084 acciones.
  • La posición subyacente de RSU vinculada al premio ejercido se redujo a cero.
  • En la misma fecha, la directora recibió una nueva asignación de 2,344 RSU (Código de Transacción A). Estas RSU se consolidan en un solo tramo el 1 de julio de 2026 y, una vez consolidadas, se convertirán 1 a 1 en acciones comunes sin restricciones.

No se vendieron acciones ni se dispusieron derivados por consideración en efectivo. Todas las acciones reportadas se adquirieron sin costo, reflejando premios programados de compensación del consejo. Tras las transacciones, la Sra. McReynolds posee 13,084 acciones comunes directamente y 2,344 RSU que permanecen no consolidadas.

La presentación indica un continuo alineamiento patrimonial entre la directora y los accionistas, pero no representa por sí sola un evento corporativo material para BBSI.

Barrett Business Services Inc. (BBSI) – 내부자 양식 4 제출, 2025년 7월 7일자

이사 Alexandra Morehouse McReynolds는 2025년 7월 1일에 실행된 다음의 주식 거래를 보고했습니다:

  • 3,064 보통주 취득 (거래 코드 M) 제한 주식 단위(RSU) 동일 수량의 권리 확정/정산에 따라 행사가격 $0.00로 취득하였습니다. 이로써 그녀의 직접 보통주 보유량은 13,084주로 증가했습니다.
  • 행사된 RSU에 연결된 기초 RSU 보유는 0으로 감소했습니다.
  • 같은 날짜에 이사는 새로운 2,344 RSU 부여를 받았습니다 (거래 코드 A). 이 RSU는 2026년 7월 1일 단일 분할로 권리가 확정되며, 권리 확정 시 1대1 비율로 제한 없는 보통주로 전환됩니다.

주식 매도나 현금 대가로 파생상품 처분은 없었습니다. 보고된 모든 주식은 무상으로 취득되었으며, 이사회 보상으로 예정된 지급을 반영합니다. 거래 후 McReynolds 이사는 직접 13,084 보통주와 아직 권리가 확정되지 않은 2,344 RSU를 보유하고 있습니다.

이번 제출은 이사와 주주 간 지속적인 주식 연계를 나타내지만, 단독으로 BBSI에 중대한 기업 사건을 의미하지는 않습니다.

Barrett Business Services Inc. (BBSI) – Déclaration d’initié Formulaire 4 datée du 7 juillet 2025

La directrice Alexandra Morehouse McReynolds a déclaré les transactions sur actions suivantes effectuées le 1er juillet 2025 :

  • Acquisition de 3 064 actions ordinaires (Code de transaction M) à la suite de l’acquisition/la levée d’un nombre égal d’Unités d’Actions Restreintes (RSU) à un prix d’exercice de 0,00 $. Cela a porté sa détention directe d’actions ordinaires à 13 084 actions.
  • La position sous-jacente des RSU liée à la levée a été réduite à zéro.
  • Le même jour, la directrice a reçu une nouvelle attribution de 2 344 RSU (Code de transaction A). Ces RSU seront acquises en une seule tranche le 1er juillet 2026 et, une fois acquises, seront converties à raison de 1 pour 1 en actions ordinaires librement négociables.

Aucune action n’a été vendue et aucun produit dérivé n’a été cédé contre une contrepartie en espèces. Toutes les actions déclarées ont été acquises sans frais, reflétant les attributions prévues dans le cadre de la rémunération du conseil d’administration. Après ces transactions, Mme McReynolds détient directement 13 084 actions ordinaires et 2 344 RSU qui restent non acquises.

Cette déclaration témoigne d’un alignement continu des intérêts en actions entre la directrice et les actionnaires, mais ne constitue pas en soi un événement d’entreprise significatif pour BBSI.

Barrett Business Services Inc. (BBSI) – Insider Form 4 Einreichung vom 7. Juli 2025

Die Direktorin Alexandra Morehouse McReynolds meldete die folgenden Aktiengeschäfte, die am 1. Juli 2025 durchgeführt wurden:

  • Erwerb von 3.064 Stammaktien (Transaktionscode M) durch die Fälligkeit/Abwicklung einer gleichen Anzahl von Restricted Stock Units (RSUs) zu einem Ausübungspreis von 0,00 $. Dadurch erhöhte sich ihr direkter Bestand an Stammaktien auf 13.084 Aktien.
  • Die zugrundeliegende RSU-Position, die mit der ausgeübten Zuteilung verbunden war, wurde auf null reduziert.
  • Am selben Tag erhielt die Direktorin eine neue Zuteilung von 2.344 RSUs (Transaktionscode A). Diese RSUs werden in einer einzigen Tranche am 1. Juli 2026 fällig und wandeln sich nach Fälligkeit 1:1 in unbeschränkte Stammaktien um.

Es wurden keine Aktien verkauft und keine Derivate gegen Barzahlung veräußert. Alle gemeldeten Aktien wurden kostenfrei erworben und spiegeln planmäßige Vorstandsvergütungen wider. Nach den Transaktionen hält Frau McReynolds direkt 13.084 Stammaktien sowie 2.344 RSUs, die noch nicht fällig sind.

Die Meldung signalisiert eine fortgesetzte Aktienausrichtung zwischen der Direktorin und den Aktionären, stellt jedoch für BBSI für sich genommen kein wesentliches Unternehmensereignis dar.

Positive
  • Director increased direct ownership by 3,064 shares, reinforcing insider alignment with shareholders.
  • No shares were sold; all activity involved acquisitions or new grants, avoiding negative perception of insider selling.
Negative
  • None.

Insights

TL;DR: Director adds 3,064 shares via RSU vesting and receives 2,344 new RSUs; no sales—incremental, mildly positive signal.

The Form 4 shows a routine board-compensation transaction. Exercising/settling 3,064 RSUs adds roughly 30% to the director’s previously held 10,020 shares, increasing her direct stake to 13,084 shares. The subsequent award of 2,344 RSUs extends her future ownership horizon through July 2026. Because the transactions involve no open-market purchases or disposals, the cash-flow impact is nil and there is no immediate dilution beyond the company’s existing equity-comp plan. While insider accumulation is generally viewed constructively, the scale is modest relative to BBSI’s 7 million-share float. Overall impact on valuation or liquidity is negligible.

TL;DR: Standard director equity grant/vesting—enhances alignment, but not materially impactful for investors.

The filing confirms BBSI’s practice of compensating directors with annual RSU grants that vest after one year. The one-for-one conversion and zero-cost exercise terms are consistent with typical non-employee director plans. The absence of concurrent share sales reduces the risk of negative optics around insider dispositions. From a governance perspective, rolling one-year vesting coupled with continued ownership supports long-term oversight incentives. Nonetheless, because the total shares involved are immaterial versus outstanding shares, investors should view this as routine disclosure rather than a signal of strategic change.

Barrett Business Services Inc. (BBSI) – Comunicazione interna Modulo 4 datata 7 luglio 2025

La direttrice Alexandra Morehouse McReynolds ha riportato le seguenti operazioni azionarie eseguite il 1 luglio 2025:

  • Acquisizione di 3.064 azioni ordinarie (Codice Transazione M) a seguito della maturazione/estinzione di un pari numero di Restricted Stock Units (RSU) con un prezzo di esercizio di $0,00. Ciò ha portato il suo possesso diretto di azioni ordinarie a 13.084 azioni.
  • La posizione sottostante delle RSU legate all’assegnazione esercitata è stata azzerata.
  • Nello stesso giorno, la direttrice ha ricevuto una nuova assegnazione di 2.344 RSU (Codice Transazione A). Queste RSU maturano in un’unica tranche il 1 luglio 2026 e, una volta maturate, si convertiranno 1 a 1 in azioni ordinarie senza restrizioni.

Non sono state vendute azioni né ceduti derivati per contante. Tutte le azioni riportate sono state acquisite a costo zero, in linea con le assegnazioni programmate per la remunerazione del consiglio. Dopo le transazioni, la signora McReynolds detiene 13.084 azioni ordinarie direttamente e 2.344 RSU ancora non maturate.

La comunicazione evidenzia un continuo allineamento azionario tra la direttrice e gli azionisti, ma non rappresenta di per sé un evento societario rilevante per BBSI.

Barrett Business Services Inc. (BBSI) – Presentación interna Formulario 4 fechada el 7 de julio de 2025

La directora Alexandra Morehouse McReynolds informó las siguientes transacciones de acciones realizadas el 1 de julio de 2025:

  • Adquisición de 3,064 acciones comunes (Código de Transacción M) tras el otorgamiento/liquidación de un número igual de Unidades de Acciones Restringidas (RSU) a un precio de ejercicio de $0.00. Esto incrementó su tenencia directa de acciones comunes a 13,084 acciones.
  • La posición subyacente de RSU vinculada al premio ejercido se redujo a cero.
  • En la misma fecha, la directora recibió una nueva asignación de 2,344 RSU (Código de Transacción A). Estas RSU se consolidan en un solo tramo el 1 de julio de 2026 y, una vez consolidadas, se convertirán 1 a 1 en acciones comunes sin restricciones.

No se vendieron acciones ni se dispusieron derivados por consideración en efectivo. Todas las acciones reportadas se adquirieron sin costo, reflejando premios programados de compensación del consejo. Tras las transacciones, la Sra. McReynolds posee 13,084 acciones comunes directamente y 2,344 RSU que permanecen no consolidadas.

La presentación indica un continuo alineamiento patrimonial entre la directora y los accionistas, pero no representa por sí sola un evento corporativo material para BBSI.

Barrett Business Services Inc. (BBSI) – 내부자 양식 4 제출, 2025년 7월 7일자

이사 Alexandra Morehouse McReynolds는 2025년 7월 1일에 실행된 다음의 주식 거래를 보고했습니다:

  • 3,064 보통주 취득 (거래 코드 M) 제한 주식 단위(RSU) 동일 수량의 권리 확정/정산에 따라 행사가격 $0.00로 취득하였습니다. 이로써 그녀의 직접 보통주 보유량은 13,084주로 증가했습니다.
  • 행사된 RSU에 연결된 기초 RSU 보유는 0으로 감소했습니다.
  • 같은 날짜에 이사는 새로운 2,344 RSU 부여를 받았습니다 (거래 코드 A). 이 RSU는 2026년 7월 1일 단일 분할로 권리가 확정되며, 권리 확정 시 1대1 비율로 제한 없는 보통주로 전환됩니다.

주식 매도나 현금 대가로 파생상품 처분은 없었습니다. 보고된 모든 주식은 무상으로 취득되었으며, 이사회 보상으로 예정된 지급을 반영합니다. 거래 후 McReynolds 이사는 직접 13,084 보통주와 아직 권리가 확정되지 않은 2,344 RSU를 보유하고 있습니다.

이번 제출은 이사와 주주 간 지속적인 주식 연계를 나타내지만, 단독으로 BBSI에 중대한 기업 사건을 의미하지는 않습니다.

Barrett Business Services Inc. (BBSI) – Déclaration d’initié Formulaire 4 datée du 7 juillet 2025

La directrice Alexandra Morehouse McReynolds a déclaré les transactions sur actions suivantes effectuées le 1er juillet 2025 :

  • Acquisition de 3 064 actions ordinaires (Code de transaction M) à la suite de l’acquisition/la levée d’un nombre égal d’Unités d’Actions Restreintes (RSU) à un prix d’exercice de 0,00 $. Cela a porté sa détention directe d’actions ordinaires à 13 084 actions.
  • La position sous-jacente des RSU liée à la levée a été réduite à zéro.
  • Le même jour, la directrice a reçu une nouvelle attribution de 2 344 RSU (Code de transaction A). Ces RSU seront acquises en une seule tranche le 1er juillet 2026 et, une fois acquises, seront converties à raison de 1 pour 1 en actions ordinaires librement négociables.

Aucune action n’a été vendue et aucun produit dérivé n’a été cédé contre une contrepartie en espèces. Toutes les actions déclarées ont été acquises sans frais, reflétant les attributions prévues dans le cadre de la rémunération du conseil d’administration. Après ces transactions, Mme McReynolds détient directement 13 084 actions ordinaires et 2 344 RSU qui restent non acquises.

Cette déclaration témoigne d’un alignement continu des intérêts en actions entre la directrice et les actionnaires, mais ne constitue pas en soi un événement d’entreprise significatif pour BBSI.

Barrett Business Services Inc. (BBSI) – Insider Form 4 Einreichung vom 7. Juli 2025

Die Direktorin Alexandra Morehouse McReynolds meldete die folgenden Aktiengeschäfte, die am 1. Juli 2025 durchgeführt wurden:

  • Erwerb von 3.064 Stammaktien (Transaktionscode M) durch die Fälligkeit/Abwicklung einer gleichen Anzahl von Restricted Stock Units (RSUs) zu einem Ausübungspreis von 0,00 $. Dadurch erhöhte sich ihr direkter Bestand an Stammaktien auf 13.084 Aktien.
  • Die zugrundeliegende RSU-Position, die mit der ausgeübten Zuteilung verbunden war, wurde auf null reduziert.
  • Am selben Tag erhielt die Direktorin eine neue Zuteilung von 2.344 RSUs (Transaktionscode A). Diese RSUs werden in einer einzigen Tranche am 1. Juli 2026 fällig und wandeln sich nach Fälligkeit 1:1 in unbeschränkte Stammaktien um.

Es wurden keine Aktien verkauft und keine Derivate gegen Barzahlung veräußert. Alle gemeldeten Aktien wurden kostenfrei erworben und spiegeln planmäßige Vorstandsvergütungen wider. Nach den Transaktionen hält Frau McReynolds direkt 13.084 Stammaktien sowie 2.344 RSUs, die noch nicht fällig sind.

Die Meldung signalisiert eine fortgesetzte Aktienausrichtung zwischen der Direktorin und den Aktionären, stellt jedoch für BBSI für sich genommen kein wesentliches Unternehmensereignis dar.

false 0001933567 0001933567 2025-07-01 2025-07-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): July 1, 2025

 

Neuraxis, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41775   45-5079684

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

11550 N. Meridian Street, Suite 325

Carmel, IN 46032

(Address of principal executive offices)

 

Registrant’s telephone number, including area code: (812) 689-0791

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value   NRXS   NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

As previously disclosed, on April 9, 2020, Neuraxis, Inc. (the “Company”) entered into a license and collaboration agreement (the “License and Collaboration Agreement”) with Masimo Corporation (“Masimo”). Under the License and Collaboration Agreement, the Company granted Masimo an exclusive, fully paid-up, royalty-free license to certain specifically identified patents and trademarks in a limited field of use, in connection with the NSS-2 Bridge device—a percutaneous nerve field stimulator (PNFS) indicated for use in the reduction of the symptoms of opioid withdrawal. The licensed patents are generally directed to the NSS-2 Bridge device and the treatment of opioid withdrawal symptoms. The licensed trademarks are generally directed to the NSS-2 Bridge mark. Masimo paid a one-time fee of $250,000. Masimo marketed and sold this product as its Masimo Bridge.

 

On July 1, 2025, the Company entered into a termination agreement (the “Termination Agreement”) with Masimo to terminate the License and Collaboration Agreement. Pursuant to the Termination Agreement, the Company agreed to pay Masimo $200,000 in cash, in two equal installments due on December 31, 2025, and June 30, 2026, for products and assets related thereto, the licensed trademark, and patents related to the products. As a result, the Company will no longer receive any licensing payments or other revenue from the NSS-2 Bridge device.

 

The foregoing description of the Termination Agreements is not complete and is qualified in its entirety by reference to the full text of the form of Termination Agreement, a copy of which is filed as Exhibits 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.

 

Item 1.02 Termination of a Material Definitive Agreement.

 

The information contained in Item 1.01 is incorporated by reference herein.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On July 1, 2025, the compensation committee of the board of directors (the “Board”) of the Company adopted the Neuraxis, Inc. 2025 Employee Stock Purchase Plan (the “Employee Stock Purchase Plan”), effective as of the same date. While the Employee Stock Purchase Plan is already effective, stockholder approval must be obtained within 12 months of July 1, 2025.

 

The purpose of the Employee Stock Purchase Plan is to give eligible employees of the Company an opportunity to acquire an ownership interest in the Company by providing eligible employees the opportunity to purchase shares of the Company’s common stock at a 15% discount using payroll deductions.

 

The maximum number of shares of the Company’s common stock that may be issued under the Employee Stock Purchase Plan is 100,000, subject to an annual increase on January 1 of each year from 2026 through 2035 by the lesser of (i) 1% of the Company’s outstanding capital stock as of the prior December 31 or (ii) 100,000 shares. The Board may reduce or eliminate this annual increase before February 1 of any given year.

 

The Employee Stock Purchase Plan is intended to qualify as an “employee stock purchase plan” within the meaning of Section 423 of the Internal Revenue Code of 1986, as amended. The length of the offering periods under the Employee Stock Purchase Plan will be determined by the plan administrator and may be up to 27 months long. The plan administrator will determine the terms of any offering periods.

 

The foregoing description of the Employee Stock Purchase Plan does not purport to be complete and is qualified in its entirety by reference to the complete text of the Employee Stock Purchase Plan which is filed as Exhibit 10.2 to this Current Report on Form 8-K and are incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit

Number

  Exhibits
10.1*   Termination Agreement, dated July 1, 2025, by and between Neuraxis, Inc. and Masimo Corporation
10.2   Neuraxis, Inc. 2025 Employee Stock Purchase Plan
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* The schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 3, 2025 NEURAXIS, INC.
   
  By: /s/ Brian Carrico
  Name: Brian Carrico
  Title: President and Chief Executive Officer

 

 

FAQ

How many Barrett Business Services (BBSI) shares did the director acquire?

Alexandra Morehouse McReynolds acquired 3,064 common shares through RSU settlement on 1 July 2025.

What is the director’s total BBSI shareholding after the Form 4 transactions?

Her direct holdings increased to 13,084 common shares, plus 2,344 unvested RSUs.

Were any Barrett Business Services shares sold in this filing?

No. The Form 4 shows only acquisitions and new RSU grants; no shares were disposed of.

When will the newly granted 2,344 RSUs vest?

The new RSUs vest in one installment on 1 July 2026.

What was the exercise price for the RSU conversion?

The RSUs converted at $0.00, reflecting standard equity-compensation terms.
Neuraxis Inc

NYSE:NRXS

NRXS Rankings

NRXS Latest News

NRXS Latest SEC Filings

NRXS Stock Data

24.58M
6.55M
50.7%
5.57%
0.16%
Biotechnology
Electromedical & Electrotherapeutic Apparatus
Link
United States
CARMEL